A Phase II Study of MGC018 in Patients With Relapsed or Refractory Extensive-Stage Small-Cell Lung Cancer

Conditions: Extensive-stage Small-cell Lung Cancer Interventions: Drug: MGC018 Sponsors: Georgetown University; MacroGenics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials